Federal Register / Vol. 62, No. 165 / Tuesday, August 26, 1997 / Notices 45271

releases or threatened releases of

hazardous substances at the site, and the

defendants will implement the remedy

at the site.

The Department of Justice will receive

comments relating to the proposed

Partial Consent Decree for a period of 30

days from the date of this publication.

Comments should be addressed to the

Assistant Attorney General of the

Environment and Natural Resources

Division, Department of Justice,

Washington, D.C. 20530. All comments

should refer to United States v.

Consolidated Rail Corp., et al., D.J. Ref.

90–11–3–594. Commenters may request

an opportunity for a public meeting in

the affected area, in accordance with

Section 7003(d) of the Resource

Conservation and Recovery Act, 42

U.S.C. § 6973(d).

The proposed Partial Consent Decree

may be examined at the offices of the

Environmental Protection Agency, 77

West Jackson Boulevard, Chicago,

Illinois, 60604, or at the Consent Decree

Library, 1120 G Street, N.W., 4th floor,

Washington, D.C. 20005, 202–624–0892.

A copy of the proposed Partial Consent

Decree may be obtained in person or by

mail from the Consent Decree Library.

In requesting a copy (without

attachments), please enclose a check in

the amount of $22.75 for the Decree (25

cents per page reproduction costs)

payable to the Consent Decree Library.

When requesting a copy, please refer to

United States v. Consolidated Rail Corp.

et al., D.J. Ref. No. 90–11–3–594.

Bruce S. Gelber,

Deputy Section Chief, Environmental

Enforcement Section, Environment and

Natural Resources Division.

[FR Doc. 97–22599 Filed 8–25–97; 8:45am]

BILLING CODE 4410–15–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1301.34 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on May 29, 1997, Applied

Science Labs, Inc., A Division of Altech

Associates, Inc., 2701 Carolean

Industrial Drive, P.O. Box 440, State

College, Pennsylvania 16801, made

application by renewal to the Drug

Enforcement Administration to be

registered as an importer of the basic

classes of controlled substances listed

below:

Drug Schedule

Heroin (9200) ................................ I

Morphine (9300) ........................... II

The firm plans to import these

controlled substances for the

manufacture of reference standards.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of these basic classes of

controlled substances may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.43 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections, or

requests for a hearing may be addressed,

in quintuplicate, to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration, United States

Department of Justice, Washington, DC

20537, Attention: DEA Federal Register

Representative (CCR), and must be filed

no later than (30 days from publication).

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1301.34 (b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import basic classes of

any controlled substances in Schedule I

or II are and will continue to be required

to demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1301.34 (a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: July 21, 1997.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 97–22559 Filed 8–25–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1301.34 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on June 17, 1997, Bridgeway

Trading Corporation, 7401 Metro Blvd.,

Suite 480, Minneapolis, Minnesota

55439, made application by renewal to

the Drug Enforcement Administration to

be registered as an importer of

marihuana (7360) a basic class of

controlled substance in Schedule I.

This application is exclusively for the

importation of marihuana seed which

will be rendered non-viable and used as

bird seed.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of this basic class of

controlled substance may file writtten

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.43 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections, or

requests for a hearing may be addressed,

in quintuplicate, to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration, United States

Department of Justice, Washington, D.C.

20537, Attention: DEA Federal Register

Representative (CCR), and must be filed

no later than (30 days from publication).

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1301.34 (b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import basic classes of

any controlled substances in Schedule I

or II are and will continue to be required

to demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements